2022 MMIT Patient Choice Awards Finalist
Senderra is a 2022 MMIT Patient Choice Awards Finalist!
Senderra is a 2022 MMIT Patient Choice Awards Finalist!
Senderra is a finalist in the Managed Markets Insight & Technology (MMIT) seventh-annual Specialty Pharmacy Patient Choice Awards as ranked by patient satisfaction survey results from the previous year.
Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care.
Senderra is honored to be a finalist this year in the Independent Specialty Pharmacy category. This honor confirms Senderra’s ongoing commitment to keeping people first and providing exceptional patient care.
Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services.
We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.
Senderra is a 2022 MMIT Patient Choice Awards Finalist!
D2 Solutions and Senderra Specialty Pharmacy launch UltraTouch™, a network collaboration to improve market access for patient services for specialty...
Senderra's Vice President Of Regulatory And Compliance, Tiffany Jones, attended a forum on the impact of pharmacy benefit managers (PBMs) in...